Innovative, cost effective products like the FemExam pH and Amines TestCard will help us maintain our position as the recognized leader in women's health disease management.
The FemExam pH and Amines TestCard, already approved by the FDA, is a rapid, economic, point of care diagnostic test that combines on a small disposable card two tests that are indicative of BV and commonly used in the differential diagnosis of vaginitis.
Reichmann, President of Women's Health at Matria, stated, "We will integrate the FemExam pH and Amines TestCard into our current disease management strategy for women's health.
Vice President of Medical Affairs at Matria, "Unlike the common testing methods used to detect BV, which are often inconvenient, subjective and costly, the FemExam pH and Amines TestCard requires no culturing or microscopic examination and provides results almost immediately.
The Gardnerella TestCard is the second of four screening or diagnostic tests for the women's healthcare market developed under CSI's licensing agreement with Litmus Concepts Inc.
In a separate announcement last month, CSI said it had agreed to co-market its FemExam pH and Amines TestCard in the United States both with 3M Pharmaceuticals, a division of 3M (NYSE:MMM), and Matria Healthcare Inc.
com, discusses the clinical background on the FemExam TestCard and links to other sites that discuss women's healthcare.